PURI COLL Rh Recombinant Human Collagen Booster

Aeterderm

Injectable skin booster

Recombinant human collagen biostimulator / skin rejuvenation injectable

Manufactured in South Korea under controlled laboratory and factory conditions using recombinant DNA technology.
Animal Free collagen source, supporting ethical and regulatory preferences over animal Derived collagen.
Marketed as a medical device/skin booster in many aesthetic markets; local regulatory classification and approvals vary by country and should be confirmed before use.

Manufactured in South Korea under controlled laboratory and factory conditions using recombinant DNA technology.
Animal Free collagen source, supporting ethical and regulatory preferences over animal Derived collagen.
Marketed as a medical device/skin booster in many aesthetic markets; local regulatory classification and approvals vary by country and should be confirmed before use.
Produced by WEDERM, an OEM/medical aesthetics manufacturer with international export markets (e.g. Brazil, Kazakhstan, Thailand, UAE), indicating compliance with relevant export and quality standards in those regions.

Description

PURI COLL Rh is a next-generation injectable skin booster based on 100% human-identical recombinant collagen Types I and III, engineered via recombinant DNA expression vector technology. The product combines recombinant human collagen (7.5 mg Type I + 7.5 mg Type III) with hyaluronic acid, PDRN (polynucleotide), succinic acid and multi-peptides to deliver both immediate structural support and long-term dermal regeneration. Because the collagen genome is 100% identical to endogenous human collagen, PURI COLL Rh offers high biocompatibility with minimal risk of immune rejection, rapid integration into tissue and an extended molecular lifespan. Clinically, it provides superior cell activity compared with animal-derived collagen, enhances wound repair and improves tissue regeneration, making it suitable for non-invasive facial rejuvenation (nasolabial folds, crow’s feet, forehead lines) and body areas with laxity (neck, elbows, knees) while maintaining a natural look without volumising filler effects.

Bnefits

100% human-identical recombinant collagen (Type I + Type III) for high biocompatibility and minimal immune reaction.
Dual collagen action: Type I collagen provides immediate structural scaffolding and lifting; Type III collagen supports long-term regeneration and dermal remodelling.
Enhanced formulation including hyaluronic acid for hydration, PDRN for tissue repair, succinic acid for fibroblast activation and multi-peptides for firming and wrinkle reduction.
Clinically reported superior wound repair efficacy (around 78% within 24 hours) compared with animal-derived collagen (around 57%).
Increases tissue regeneration (reported improvement of about 52.8%) and fibroblast activity (around 15–19% higher cell activity than animal collagen).
Improves skin firmness, elasticity and texture while reducing fine lines and wrinkles in face, neck and body areas.
Provides visible lifting and tightening with progressive improvement over weeks as new collagen and elastin are synthesised.
Animal-free recombinant technology, reducing risks associated with animal-derived collagen and supporting ethical, sustainable sourcing.
Can be combined with other aesthetic modalities (RF microneedling, lasers, mesotherapy, LED, etc.) for synergistic regenerative effects.
Designed for natural-looking rejuvenation rather than volumetric filling, maintaining facial expression and contours.